A cohort study found that GLP-1RAs were associated with a reduced risk of hepatic decompensation and mortality in individuals with type 2 diabetes cirrhosis (Yen et al., 2024)
This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food, or cosmetic
The mechanisms underlying these hepatoprotective effects include reduced hepatic lipogenesis (fat production), enhanced fatty acid oxidation, and decreased inflammatory cytokine production
All information provided is for educational and research purposes only , and this product must never be used in humans or animals
10.1001/jamanetworkopen.2025.16381 38 GoldbergD.DitahI
thats how youll get prequalified for a GLP-1